Liverpool Skylilne

Pharmacy and Biomolecular Sciences

Dr Peter Penson

Dr Peter Penson

Telephone: 0151 231 2071

website
google Scholar
ORCID

Biography

Dr Peter Penson is a Senior Lecturer in Pharmacology and Pharmacy Practice at Liverpool John Moores University, UK, Honorary Research Associate at Univerity of Liverpool, UK and an active member of the Liverpool Centre for Cardiovascular Science. In addition, Dr Penson is an Executive Editor of the British Journal of Clinical Pharmacology, Associate Editor of BMC Pharmacology and Toxicology and a Section Editor of Archives of Medical Science: Civilisation Diseases. A Fellow of the Higher Education Academy, he has conducted research at Cardiff University and the University of Surrey, both in the UK, and at the University of Regensburg, Germany. Dr Penson’s research interests include cardiovascular pharmacology and clinical outcomes in cardiovascular disease, with a particular focus on hypertension, dyslipidaemias and ischaemia-reperfusion injury. He is primarily involved in observational studies, clinical trials and meta-analysis. He is a member of the International Lipid Expert Panel and he works with many international experts in the Lipid and Blood Pressure Meta-Analysis Collaboration Group. A pharmacist, registered with the UK General Pharmaceutical Council, Dr Penson is a fellow of The European Society of Cardiology, and a member of The British Cardiovascular Society, The British Pharmacological Society and The British Society for Cardiovascular Research.

Dr Penson teaches cardiovascular physiology, pharmacology and therapeutics on the MPharm. programme. As a pharmacist, he is also involved in teaching Pharmacy Practice elements of the course. He has responsibility for undergraduate and postgraduate masters projects in addition to supervising PhD candidates. Dr Penson leads the third-year of the M.Pharm curriculum, which is organised as a single 120-credit module called 'Complexities of Healthcare'.

Dr Penson is currently an External Examiner for Undergraduate Programmes at UWE Bristol, he has acted as an external examiner for postgraduate Degrees at Coventry University and the University of Birmingham.

He has carried out pedagogic research into the use of lectures and electronic media in teaching and learning in undergraduate pharmacy education. He led a team which conducted a funded research project to identify the learning needs of pharmacists and pharmacy staff in relation to delivery of commissioned services. He is a Fellow of the Higher Education Academy. In 2019 he was designated as a Fellow of the European Society of Cardiology. The fellowship was awarded for scientific excellence.

Degrees

2009, Cardiff University, United Kingdom, Ph.D.
2004, University of Wales, United Kingdom, M.Pharm.

Academic appointments

Honorary Research Associate, University of Liverpool, 2019 - present
Senior Lecturer in Pharmacology and Pharmacy Practice, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 2009 - present

Postgraduate training

Postgraduate Certificate in Learning and Teaching in Higher Education, United Kingdom, Liverpool John Moores University, 2009 - 2010

Publications

Highlighted publications

Penson P. 2020. Spotlight Commentary: What’s new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes British Journal of Clinical Pharmacology, DOI Author Url Public Url

Banach M, Penson P, Fras Z, Vrablik M, Pella D, Reiner Z, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M, FH Europe , International Lipid Expert Panel (ILEP) . 2020. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic Pharmacological Research, DOI Author Url Public Url

Mazidi M, Mikhailidis DP, Sattar N, Toth PP, Judd S, Blaha MJ, Hernandez AV, Penson P, Banach M. 2020. Association of Types of Dietary Fats and All-Cause and Cause-Specific Mortality: A Prospective Cohort Study and Meta-Analysis of Prospective Studies with 1,148,117 Participants Clinical Nutrition, DOI Public Url

Banach M, Penson P. 2019. Statins and Lp(a): Don’t make perfect the enemy of excellent. European Heart Journal, DOI Author Url

Banach M, Penson P. 2019. Genetic testing in familial hypercholesterolaemia: What does it add? European Journal of Preventative Cardiology, DOI Author Url

Penson P, Long L, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2019. Associations between cardiovascular disease, cancer and very low HDL cholesterol in the REasons for Geographical And Racial Differences in Stroke (REGARDS) study. Cardiovascular Research, 115 :204-212 DOI Author Url Public Url

Penson P, Mancini GBJ, Toth PP, Martin SS, Watts GF, Sahebkar A, Mikhailidis DP, Banach M. 2018. Introducing the 'Drucebo' Effect in Statin Therapy: A systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions. Journal of Cachexia, Sarcopenia and Muscle, DOI Author Url Publisher Url Public Url

Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Martin SS, Mazidi M, Catapano AL, Banach M. 2018. Associations Between Very Low Concentrations of LDL-Cholesterol, hs-CRP and Health Outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study European Heart Journal, 39 :3641-3653 DOI Author Url Public Url

Ritchie L, Qin S, Penson P, Henney N, Lip G. Vernakalant hydrochloride for the treatment of atrial fibrillation: An evaluation of its place in clinical practice Future Cardiology, DOI Author Url Public Url

Journal article

Penson P. 2020. Spotlight Commentary: What’s new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes British Journal of Clinical Pharmacology, DOI Author Url Public Url

Banach M, Penson P, Fras Z, Vrablik M, Pella D, Reiner Z, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M, FH Europe , International Lipid Expert Panel (ILEP) . 2020. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic Pharmacological Research, DOI Author Url Public Url

Gorabi AM, Penson P, Banach M, Motallebnezhad M, Jamialahmadi T, Sahebkar A. 2020. Epigenetic control of atherosclerosis via DNA methylation: a new therapeutic target? Life Sciences, DOI Author Url Public Url

Katsiki N, Mikhailidis DP, Bajraktari G, Miserez AR, Cicero AFG, Bruckert E, Serban MC, Mirrakhimov E, Alnouri F, Reiner Ž, Paragh G, Sahebkar A, Banach M. 2020. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP) Pharmacological Research, 155 DOI Author Url

Hayat SMG, Jaafari MR, Hatamipour M, Penson PE, Sahebkar A. 2020. Liposome Circulation Time is Prolonged by CD47 Coating. Protein and Peptide Letters: international journal for rapid publication of short papers in protein and peptide science, 27 DOI Author Url Publisher Url Public Url

Jahrami H, Al-Mutarid M, Penson P, Faris M, Saif Z, Hammad L. 2020. Intake of caffeine and its association with physical and mental health status among university students Foods, 9 DOI Author Url Publisher Url Public Url

Cybulska B, Kłosiewicz-Latoszek L, Penson P, Banach M. 2020. What Do We Know About the Role of Lipoprotein(a) in Atherogenesis 57 Years After its Discovery? Progress in Cardiovascular Diseases, DOI Author Url Public Url

Mazidi M, Mikhailidis DP, Sattar N, Toth PP, Judd S, Blaha MJ, Hernandez AV, Penson P, Banach M. 2020. Association of Types of Dietary Fats and All-Cause and Cause-Specific Mortality: A Prospective Cohort Study and Meta-Analysis of Prospective Studies with 1,148,117 Participants Clinical Nutrition, DOI Public Url

Shahbaz SK, Foroughi F, Soltaninezhad E, Jamialahmadi T, Penson P, Sahebkar A. 2020. Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection Expert Opinion on Drug Delivery, DOI Author Url Publisher Url Public Url

Zhubi-Bakija F, Bajraktari G, Bytyçi I, Mikhailidis DP, Henein MY, Latkovskis G, Rexhaj Z, Zhubi E, Banach M, Alnouri F, Amar F, Atanasov AG, Bartlomiejczyk MA, Bjelakovic B, Bruckert E, Cafferata A, Ceska R, Cicero AFG, Collet X, Descamps O, Djuric D, Durst R, Ezhov MV, Fras Z, Gaita D, Hernandez AV, Jones SR, Jozwiak J, Kakauridze N, Katsiki N, Khera A, Kostner K, Kubilius R, Mancini GBJ, Marais AD, Martin SS, Martinez JA, Mazidi M, Mirrakhimov E, Miserez AR, Mitchenko O, Moriarty PM, Nabavi SM, Nair D, Panagiotakos DB, Paragh G, Pella D, Penson PE, Petrulioniene Z, Pirro M, Postadzhiyan A, Puri R, Reda A, Reiner Ž, Riadh J, Richter D, Rizzo M, Ruscica M, Sahebkar A, Sattar N, Serban MC, Shehab AMA, Shek AB, Sirtori CR, Stefanutti C, Tomasik T, Toth PP, Viigimaa M, Vinereanu D, Vohnout B, von Haehling S, Vrablik M, Wong ND, Yeh HI, Zhisheng J, Zirlik A. 2020. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) Clinical Nutrition, DOI

Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, Sahebkar A. 2019. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. Journal of clinical medicine, 8 DOI Author Url Publisher Url Public Url

Dyrbuś K, Mariusz G, Penson P, Ray KK, Banach M. 2019. Inclisiran-new hope in the management of lipid disorders? Journal of Clinical Lipidology, DOI Author Url Public Url

Dehnavi S, Sadeghi M, Penson PE, Banach M, Jamialahmadi T, Sahebkar A. 2019. The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis. Journal of clinical medicine, 8 DOI Author Url Publisher Url Public Url

Shahbaz SK, Sadeghi M, Penson P, Koushki K, Sahebkar A. 2019. Regulatory T cells: possible mediators for the anti-inflammatory action of statins Pharmacological Research, DOI Author Url Public Url

Kiaie N, Gorabi AM, Penson PE, Watts G, Johnston TP, Banach M, Sahebkar A. 2019. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome Drug Discovery Today, DOI Author Url Publisher Url Public Url

Chruściel P, Stemplewska P, Stemplewski A, Wattad M, Bielecka-Dąbrowa A, Maciejewski M, Penson P, Bartlomiejczyk M, Banach M. 2019. Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study Archives of Medical Science, 15 DOI Publisher Url Public Url

Gjuladin-Hellon T, Davies IG, Penson P, Amiri Baghbadorani R. 2019. Effects of carbohydrate restricted diets on low density lipoprotein-cholesterol levels in overweight and obese adults: a systematic review and meta-analysis of large randomised controlled trials of at least 6 months Nutrition Reviews, 77 :161-180 DOI Author Url Publisher Url Public Url

Banach M, Penson PE. 2019. What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? Cardiovascular Research, 115 :e26-e31 DOI Author Url Publisher Url Public Url

Bartlomiejczyk MA, Penson P, Banach M. 2019. Worldwide Dyslipidemia Guidelines Current Cardiovascular Risk Reports, 13 DOI Publisher Url Public Url

Penson P, Long L, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2019. Associations between cardiovascular disease, cancer and very low HDL cholesterol in the REasons for Geographical And Racial Differences in Stroke (REGARDS) study. Cardiovascular Research, 115 :204-212 DOI Author Url Public Url

Banach M, Bartlomiejczyk M, Penson P. 2018. Lipoprotein(a) and the risk of atrial fibrillation – is there a link Heart Beat Journal, 2 :49-49 DOI Publisher Url Public Url

Penson P, Mancini GBJ, Toth PP, Martin SS, Watts GF, Sahebkar A, Mikhailidis DP, Banach M. 2018. Introducing the 'Drucebo' Effect in Statin Therapy: A systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions. Journal of Cachexia, Sarcopenia and Muscle, DOI Author Url Publisher Url Public Url

Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Martin SS, Mazidi M, Catapano AL, Banach M. 2018. Associations Between Very Low Concentrations of LDL-Cholesterol, hs-CRP and Health Outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study European Heart Journal, 39 :3641-3653 DOI Author Url Public Url

Franczyk B, Gluba-Brzozka A, Jurkiewicz L, Penson P, Banach M, Rysz J. 2018. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? Expert Opinion on Pharmacotherapy, DOI Author Url Publisher Url Public Url

Sosnowska B, Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. 2017. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis ATHEROSCLEROSIS, 265 :275-282 DOI Author Url Public Url

Maierean S, Serban MC, Sahebkar A, Ursoniu S, Serban A, Penson P, Banach M. 2017. The Effects of Cinnamon Supplementation on Plasma Lipid Concentrations: A Systematic Review and Meta-Analysis Journal of Clinical Lipidology, DOI Author Url Public Url

Awad K, Sahebkar A, Penson P, Mikhailidis D, Toth P, Jones S, Rizzo M, Howard G, Lip G, Banach M. 2017. Effects of Morning Versus Evening Statin Administration on Lipid Profile: A Systematic Review And Meta-Analysis Journal of Clinical Lipidology, DOI Author Url Public Url

Ursoniu S, Mikhailidis D, Serban M, Penson P, Toth P, Ridker P, Ray K, Hovingh G, Kastelein J, Hernandez A, Manson J, Rysz J, Banach M. 2017. The Effect Of Statins On Cardiovascular Outcomes By Smoking Status: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials. Pharmacological Research, DOI Author Url Public Url

Sahebkar A, Serban M-C, Penson P, Gurban C, Ursoniu S, Toth P, Jones S, Lippi G, Kotani K, Kostner K, Rizzo M, Rysz J, Banach M. 2017. The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Drugs, DOI Author Url Public Url

Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. 2017. Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease JOURNAL OF CLINICAL LIPIDOLOGY, 11 :617-623 DOI Author Url

Sosnowska B, Penson P, Banach M. 2017. THE ROLE OF NUTRACEUTICALS IN THE PREVENTION OF CARDIOVASCULAR DISEASE Cardiovascular Diagnosis and Therapy, DOI Author Url Public Url

Mazidi M, Penson P, Banach M. 2017. Association between telomere length and complete blood count in US adults. Archives of medical science : AMS, 13 :601-605 DOI Author Url Publisher Url Public Url

Penson P, Serban M-C, Ursoniu S, Banach M. 2017. Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review Critical Reviews in Food Science and Nutrition, DOI Author Url Public Url

Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, 27 :251-259 DOI Author Url Public Url

Awad K, Penson P, Banach M. 2016. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent Pharmacological Research, 114 :42-46 DOI Author Url Public Url

Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, DOI Author Url Public Url

Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, DOI Author Url Public Url

Brie D, Penson P, Serban M-C, Toth P, Serruys P, Banach M. 2016. Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, DOI Author Url Public Url

Dinca M, Serban M-C, Sahebkar A, Mikhailidis D, Toth P, Martin S, Blaha M, Blueher M, Gurban C, Penson P, Michos E, Hernandez A, Jones S. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, DOI Author Url Public Url

Penson PE. 2012. Lecturing: A lost art Currents in Pharmacy Teaching and Learning, 4 :72-76 DOI

Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M-3) RECEPTORS COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 76 :781-801 DOI Author Url

Penson PE, Ford WR, Kidd EJ, Broadley KJ. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn-Schmiedeberg's archives of pharmacology, 378 :589-597 DOI Author Url

Penson PE, Ford WR, Broadley KJ. Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice? Pharmacology & therapeutics, 115 :37-55 DOI Author Url Public Url

Broadley KJ, Penson PE. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. European journal of pharmacology, 536 :279-286 DOI Author Url

Broadley KJ, Penson PE. The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia. Autonomic & autacoid pharmacology, 24 :87-93 DOI Author Url

Ritchie L, Qin S, Penson P, Henney N, Lip G. Vernakalant hydrochloride for the treatment of atrial fibrillation: An evaluation of its place in clinical practice Future Cardiology, DOI Author Url Public Url

Other

Thompson C, Madden J, Penson P. 2020. Research Protocol Registration: Systematic review to determine the chemical space of existing physiologically-based kinetic (PBK) models PROSPERO 2020 CRD42020171130, Publisher Url

Penson P, Mazidi M, Bartłomiejczyk M, Rakowski M, Jankowski P, Hernandez AV, Banach M. 2020. Research Protocol Registration: Risk factors associated with contracting COVID-19, and mortality PROSPERO 2020 CRD42020175666, Publisher Url

Penson P. 2019. Research Protocol Registration: Comparing the effects of statin monotherapy, and statins in combination, with other lipid-lowering agents on plasma lipoprotein(a) PROSPERO 2019 CRD42019145229, Publisher Url

Mozidi M, Penson P, Banach M. 2019. Research Protocol Registration: Risk factors for statin intolerance PROSPERO 2019 CRD42019145189, Publisher Url

Penson P, Banach M. 2017. Research Protocol Registration: A systematic review and meta-analysis to compare reported rates of statin-associated muscle symptoms, under blinded and open-label conditions PROSPERO, :PROSPERO 2017-CRD42017082700 Author Url Publisher Url

Banach M, Awad K, Penson P, Lane D, Lip GYH. 2016. Research Protocol Registration: The prognostic accuracy of stroke risk prediction scores for patients with atrial fibrillation: a systematic review and meta-analysis :PROSPERO 2016-CRD42016052271 Author Url Publisher Url

Banach M, Awad K, Penson P, Lane D, Lip GYH. 2016. Research Protocol Registration: The prognostic accuracy of risk prediction scores for bleeding: a systematic review and meta-analysis :PROSPERO 2016-CRD42016052259

Penson P, Serban MC, Banach M. 2016. Research Protocol Registration: Association of cholesterol efflux activity with major adverse cardiovascular events :PROSPERO 2016-CRD42016039035 Author Url Publisher Url

Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Banach M. 2016. Research Protocol Registration: Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis :PROSPERO 2016-PROSPERO 2016 Author Url Publisher Url

Serban MC, Penson P, Sahebkar A, Ursoniu S, Gurban C, Banach M. 2016. Research Protocol Registration: Impact of tamoxifen on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of prospective studies :PROSPERO 2016-CRD42016036890 Author Url Publisher Url

Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow W, Muntner P, Lip G, Wong N, Rysz J. 2016. Research Protocol Registration: Effects of Pentoxifylline on blood pressure and inflammatory markers: a systematic review and meta-analysis of randomized controlled trials :PROSPERO 2016-CRD42016035988 Author Url Publisher Url

Penson P, Serban MC, Andrica F, Banach M. 2015. Research Protocol Registration: Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review and meta-analysis :PROSPERO 2015-CRD42015032335 Author Url Publisher Url

Chapters

Bartlomiejczyk M, Penson P, Banach M. 2020. Vitamin D and SAMS Thompson PD, Taylor B. Statin-Associated Muscle Symptoms Humana Press 978-3-030-33303-4 DOI

Penson P, Henney N. Homeostasis Gaskell E, Rostron C. Therapeutics and Human Physiology OUP Oxford 9780199655298 Author Url

Henney N, Penson P. Communication systems in the body - neural Gaskell E, Rostron C. Therapeutics and Human Physiology OUP Oxford 9780199655298 Author Url

Bartłomiejczyk M, Penson P, Banach M. Management of Statin Intolerance Davidson M, Toth PP, Maki K. Therapeutic Lipidology 2nd Ed SpringerNature

Editorial/letter to the editor

Banach M, Penson P. 2019. Statins and Lp(a): Don’t make perfect the enemy of excellent. European Heart Journal, DOI Author Url

Ritchie L, Penson P, Lane D. 2019. Warfarin therapy and improved anticoagulation control by patient self-management Thrombosis and Haemostasis, DOI Author Url

Banach M, Penson P. 2019. Genetic testing in familial hypercholesterolaemia: What does it add? European Journal of Preventative Cardiology, DOI Author Url

Penson P. 2017. Autonomic and Autacoid Pharmacology: Goodbye and thank you Autonomic and Autacoid Pharmacology, DOI Author Url

Penson PE. 2016. Autonomic & Autacoid Pharmacology 2016: The year in review. Auton Autacoid Pharmacol, 36 :27-27 DOI Author Url

Penson P. 2016. Autonomic & Autacoid Pharmacology: past, present and future Autonomic and Autacoid Pharmacology, DOI Author Url

Penson P. 2007. Peter Penson on one way to cut the NHS drugs budget The Health service journal, Author Url Publisher Url

Penson PE. 2006. Wasted journey [15] Pharmaceutical Journal, 276 :322

Penson PE. 2005. Academic rigour? [9] Pharmaceutical Journal, 275 :752

Penson P. 2004. Apply liberally [12] Pharmaceutical Journal, 273 :644

Penson P. 2004. Peddling products of dubious safety, quality and efficacy [12] Pharmaceutical Journal, 273 :21

Penson P. 2004. Not a new hazard [5] Pharmaceutical Journal, 272 :86

Penson P. 2003. An outsider's view of our profession [3] Pharmaceutical Journal, 271 :543

Penson PE. Incense – A problematic method of drug-delivery Medical Hypotheses, 72 :482-482 DOI Author Url

Dataset

Sayre R, Grulke C, Tan Y-M, Madden J, Thompson C, Webb S, Penson P. 2019. Existing physiologically-based kinetic (PBK) models, identified via PubMed searches (with associated EndNote library) DOI

Conference publication

Penson P, Toth P, Mikhailidis D, Ezhov M, Fras Z, Mitchenko O, Pella D, Sahebkar A, Rysz J, Reiner Z, Jozwiak J, Mazidi M, Banach M. 2019. P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel European Heart Journal, 40 DOI

Mahmoud A, Mullen R, Penson P, Morecroft C. 2019. Exploring the management and control of adult asthma patients: stakeholder perspectives in the North West of England International Journal of Pharmacy Practice, Health Services Research & Pharmacy Practice Conference 27 :49-49 DOI

Penson PE, Awad K, Lane D, Banach M, Lip GYH. 2018. P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis European Heart Journal, 39 DOI Author Url

Penson P, Long LD, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Catapano AL, Banach M. 2018. P5086Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study European Heart Journal, 39 DOI Author Url

Whiteoak A, Penson P. 2018. Novel electromechanical method for measuring toxic response in aquatic invertebrates Proc Physiol Soc, Experimental Models 40 :PC08-PC08 Author Url

Maguire E, Penson P, Davies H, McEntee J. 2017. What information about new medicines is needed by health care professionals? UKMi Practice Development Seminar :25-25 Author Url

Penson P, Long DL, Howard G, Toth PP, Muntner P, Howard VJ, Safford MM, Jones SR, Catapano AL, Banach M. 2017. P627Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study European Heart Journal, 38 DOI Author Url

Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Jones SR, Rysz J, Rizzo M, Howard G, Lip GYH, Banach M. 2017. 3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis European Heart Journal, 38 DOI Author Url

Penson P, Long DL, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M. 2017. 3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study European Heart Journal, 38 DOI Author Url

Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials European Heart Journal ( 2016 ) 37 ( ), 339, ESC Congress 2016 37 :39-39 DOI

Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, bluher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokine concentrations? a systematic review and meta-analysis of randomized controlled trials. European Heart Journal, ESC Congress, 2016 37 :546-547 DOI Author Url

Ursoniu S, Mikhailidis DP, Serban MC, Penson P, Toth PP, Ray KK, Kastelein JJP, Hernandez AV, Banach M. 2016. The effects of statins on cardiovascular outcomes by smoking status. a systematic review and meta-analysis of randomized controlled trials European Heart Journal, ESC Congress 2016 37 :991-992 DOI Author Url

Brie D, Sahebkar A, Dinca M, Ursoniu S, Penson P, Serban MC, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials EUROPEAN HEART JOURNAL, Congress of the European-Society-of-Cardiology (ESC) 37 :339-339 Author Url

Krska J, Stokes E, Penson P, Mackridge A . 2013. Training needs of pharmacy staff providing an alcohol screening service The 9th Conference of INEBRIA Author Url

Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. ChemInform Abstract: Synthesis of Antagonists of Muscarinic (M3) Receptors. ChemInform, 42 :no-no DOI

Penson P, Ford W, Broadley K. 2007. Infarct-size reduction induced by ischaemic postconditioning is dependent on β2-adrenoceptor activation in the Langendorff perfused rat heart Proceedings of the British Pharmacological Society, British Pharmacological Society, Winter Meeting December 2007 :030p-030p Author Url Publisher Url

Penson P, Ford W, Kidd E, Broadley K. 2006. Preconditioning by the β-adrenoceptor agonist, isoprenaline, in the rat isolated atrium but not ventricle pA2 Online, British Pharmacological Society 75th Anniversary Meeting December 2006 :115P-115P Author Url Publisher Url

Penson PE, Krska J, Stokes E, Mackridge AJ. Developing skills to deliver alcohol screening and brief intervention (SBI) in community pharmacy Addiction Science & Clinical Practice, 8 DOI Publisher Url

Penson PE, Ford WR, Kidd EJ, Broadley KJ. Protective role of β2- and β3-adrenoceptors at reperfusion in isolated rat heart Journal of Molecular and Cellular Cardiology, 44 :719-719 DOI Author Url

M. Whiteoak A, E. Penson P. 220 Daphnia magna as a model for quantifying chaos in cardiac arrhythmia Heart, 103 :A143.2-A143 DOI Author Url

Penson P, Martin SS, Henney N, Banach M. Comparison of LDL-C calculation by Friedewald and Martin/Hopkins methods in 12,243 adults from the United States of America European Society of Cardiology Congress 2020

Report

Stokes E, Penson P, Mackridge A, Krska J. 2012. Evaluation of the training needs of pharmacy staff delivering an alcohol Identification and Brief Advice (IBA) service :1-1

Book

Gaskell EE, Evans A, Henney N, Penson P, Elliott PNC, Burrell H, Airley R, Ford W, Lane E, Allison GL. Therapeutics and Human Physiology Gaskell EE, Rostron C. OUP Oxford. Oxford, UK 9780199655298 Author Url Publisher Url

Thesis/Dissertation

Penson P. β-adrenoceptor subtypes involved in myocardial preconditioning and postconditioning http://orca.cf.ac.uk/54502/ Broadley KJ, Ford WR, Kidd EJ. Cardiff University Publisher Url

Engagement & Impact

Highlighted activities

External PGR examinations performed:

Liverpool John Moores University, MPhil, An investigation into the implications of switching to extended intermittent infusions rather than standard practice of antibiotic administration in critically ill patients with sepsis. 2019

University of Birmingham, PhD, Anticoagulation control in patients with AF. 2019

Other Professional Activity:

External Examiner, Faculty of Health and Applied Sciences, UWE Bristol (2018-2022).

Professional activities

Editorial boards:

British Journal of Clinical Pharmacology, Executive Editor. 2020

BMC Pharmacology and Toxicology, Associate Editor. 2017

The Young Darwinian, Member of Editorial Board. 2017

Archives of Medical Science - Civilization Diseases, Section Editor. 2016

Autonomic and Autacoid Pharmacology, Editor-In-Chief. 2016

Conference organisation:

Pharmacology 2019 (British Pharmacological Society), Abstract Reviewer. 2019

Pharmacology 2018 (British Pharmacological Society), Abstract Reviewer. 2018

Pharmacology 2017 (British Pharmacological Society), Abstract Reviewer. 2017

Autonomic, Respiratory and Cardiovascular Pharmacology: A Festschrift Symposium in Honour of the 65th Birthday of Professor Ken Broadley., Organiser. 2008

Other invited event:

Heart UK 33rd Annual Medical & Scientific Conference, Warwick UK, Invited Lecture: Evidence-based use of lipid-lowering nutraceuticals. 2019

Heart UK 15th Northwest Diabetes, Endocrinology and Cardiovascular Update, Manchester, United Kingdom, Invited Lecture: Nutraceuticals in Clinical Practice. 2018

Heart UK 11th North West Lipid and Atherosclerosis Forum, Manchester UK, Keynote Lecture: Lipid-Lowering Nutraceuticals in Clinical Practice. 2018

Invited Talk: Management of Statin Intolerance, International Lipid Expert Panel (Munich, Germany), Invited Talk. 2018

5th Meeting of the Hyperlipidemia Academy, Madrid, Spain, Invited Lecture. 2017

2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Vienna, Session Chair: Heart Failure management in the elderly. 2017

2nd Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Vienna, Invited Lecture: Lipids as Predictors of Clinical Outcomes in Older Adults. 2017

The heart of the matter: Insights into cardiovascular risk reduction from the Lipid and Blood Pressure Meta-Analysis Collaboration Group, University of Salford, Invited Seminar. 2017

The 1st Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals, Bratislava, Slovakia, Session Chair: Nutraceuticals. 2016

Seminar: Careers in Academia, Cardiff University, Careers in Academia. 2014

Membership of professional bodies:

Member, Cochrane. 2019

Member, British Cardiovascular Society, https://www.bcs.com/pages/default.asp. 2016

Member, European Society of Cardiology, http://www.escardio.org/. 2016

Ordinary Member, European Society of Cardiology. 2015

Member, British Society for Heart Failure, http://www.bsh.org.uk/. 2015

Member of the British Society for Cardiovascular Research, British Society for Cardiovascular Research. 2009

British Pharmacological Society (Full Member), British Pharmacological Society. 2005

Member of the Royal Pharmaceutical Society, Royal Pharmaceutical Society. 2005

External PGR examinations performed:

Liverpool John Moores University, MPhil, An investigation into the implications of switching to extended intermittent infusions rather than standard practice of antibiotic administration in critically ill patients with sepsis. 2019

University of Birmingham, PhD, Anticoagulation control in patients with AF. 2019

Coventry University, MPhil, TBC. 2010

Research Grants Awarded:

European Partnership for Alternative Approaches to Animal Testing, Tools to Support Application of Physiologically-Based Kinetic Modelling in Safety Assessment, Dr Judith C. Madden (LJMU), Dr Steven Webb (LJMO), Grant value (£): 82,000, Duration of research project: 3 Years. 2019

Isra University, Jordan, Phd Studentship, Adam Mackridge, Rachel Mullen, Grant value (£): 23,400, Duration of research project: 3 Years. 2017

Sefton Primary Care Trust, Design, implementation and evaluation of an educational intervention to assist pharmacy staff in delivering an Alcohol IBA scheme, Mackridge,A; Krska,J, Grant value (£): 13000, Duration of research project: 1/1. 2011

Award:

Top 1% Reviewer in the field of Clinical Medicine, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=8. 2018

Top 1% Reviewer in the field of Multidisciplinary Research, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=22. 2018

Top 1% Reviewer in the field of Pharmacology and Toxicology, Publons, https://publons.com/awards/2018/esi/?name=Peter%20Penson&esi=5. 2018

Publons: Top 1% of Peer reviewers in the field of Medicine (64th place worldwide), Publons Peer Review Awards 2017, http://bit.ly/Publons17. 2017

Publons: Sentinels of Science 2016: Top 10% Reviewer in the field of Medicine, Publons, http://bit.ly/Publons16. 2016

Nominated for Amazing Teaching Award (2016), Liverpool Students' Union. 2016

Nominated for Amazing Teaching Award (2015), Liverpool Students' Union. 2015

Nominated for Amazing Teaching Award (2013), Liverpool Students' Union. 2013

Prize Awarded for Outstanding Poster, International Network on Brief Interventions for Alcohol and Other Drugs at the 9th International INEBRIA conference, Barcelona, http://bit.ly/Inebria9. 2012

The GlaxoSmithKline Award for the Best Pharmacology Student, The Science, Engineering & Technology Student of the Year Awards and the British Pharmacological Society. 2004

External committees:

International Lipid Expert Panel, (ILEP), http://ilep.eu/. 2018

Abstract Reviewer, British Pharmacological Society (Pharmacology 2017). 2017

Lipid and Blood Pressure Meta-analysis Collaboration Group, (LBPMCG), http://lbpmcgroup.umed.pl/. 2015

Teaching qualification:

PGCert Learning and Teaching in Higher Education. 2011

Fellowships:

Higher Education Academy, Higher Education Academy. 2010

Other Professional Activity:

External Examiner, Faculty of Health and Applied Sciences, UWE Bristol (2018-2022).